Compare BBY & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBY | HOLX |
|---|---|---|
| Founded | 1966 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 16.6B |
| IPO Year | N/A | 1990 |
| Metric | BBY | HOLX |
|---|---|---|
| Price | $70.22 | $74.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 13 |
| Target Price | ★ $81.53 | $77.89 |
| AVG Volume (30 Days) | ★ 4.3M | 2.7M |
| Earning Date | 03-03-2026 | 01-29-2026 |
| Dividend Yield | ★ 5.40% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.02 | 2.40 |
| Revenue | ★ $41,825,000,000.00 | $4,126,500,000.00 |
| Revenue This Year | $1.72 | $6.74 |
| Revenue Next Year | $1.27 | $5.48 |
| P/E Ratio | ★ $23.30 | $31.13 |
| Revenue Growth | N/A | ★ 2.17 |
| 52 Week Low | $54.99 | $51.90 |
| 52 Week High | $91.68 | $75.36 |
| Indicator | BBY | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 49.63 |
| Support Level | $62.77 | $74.50 |
| Resistance Level | $69.05 | $74.99 |
| Average True Range (ATR) | 1.90 | 0.43 |
| MACD | 0.50 | -0.06 |
| Stochastic Oscillator | 96.02 | 82.79 |
With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.